Brylie Lundy’s journey began when her mother, Sherri, found a small lump on Brylie’s chest and panicked, fearing the worst. Sherri and her husband, Greg, immediately took Brylie to her pediatrician, who assured them that it was likely just some extra tissue and nothing to worry about. Over the next few months, they returned several times believing the lump had grown, but an ultrasound showed nothing unusual. A second opinion provided no concrete answers, so Brylie and her parents met with surgeon Julie Glasson, M.D., at Children’s Healthcare of Atlanta.
Dr. Glasson ordered an MRI, which quickly confirmed their fears: There was a tumor in Brylie’s chest that was too large to remove, and it was most likely cancer. “Your world stops,” said Sherri. “There are no words to describe that moment.” From then on, the Lundys faced a whirlwind of appointments and tests to determine the exact type of cancer Brylie had. After a biopsy, port installation, CT scan, bone marrow extraction and more, oncologist Bradley George, M.D., and his team at the Aflac Cancer and Blood Disorders Center identified Brylie’s cancer as Ewing’s sarcoma. They laid out an aggressive treatment plan and started Brylie on 12 weeks of induction chemotherapy.